Skip to content

R&D at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$22.61M+0.6%
Baxter International logo
Baxter InternationalBAX
$139M-0.7%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$249M+7.3%
TFX
TeleflexTFX
$44.39M+75.5%
Edwards Lifesciences logo
Edwards LifesciencesEW
$263.3M+3.4%
Moog Inc. logo
Moog Inc.MOG.A

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's R&D?
ICU Medical (ICUI) reported R&D of $21.28M in Q1 2026.
How has ICU Medical's R&D changed year-over-year?
ICU Medical's R&D decreased by 8.6% year-over-year, from $23.29M to $21.28M.
What is the long-term trend for ICU Medical's R&D?
Over 4 years (2021 to 2025), ICU Medical's R&D has grown at a 16.5% compound annual growth rate (CAGR), from $47.5M to $87.5M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.